Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-11-23 17:11 Tx date 2021-11-23 |
$GSD
Devonian Health Group Inc. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+67,500 vol |
687,500 | |
Filed 2020-07-29 16:39 Tx date 2020-06-18 |
$GSD
Devonian Health Group Inc. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
620,000 | ||
Filed 2018-12-04 Tx date 2018-11-30 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,000
+450,000 vol $0.06 each |
450,000 | |
Filed 2018-11-05 Tx date 2018-10-31 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-32,250
-150,000 vol $0.215 each |
150,000 | |
Filed 2018-11-05 Tx date 2018-10-31 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Digital Coins or Tokens
36 - Conversion or exchange
|
$6,000
+1,500 vol $4.00 each |
||
Filed 2018-11-05 Tx date 2018-10-31 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-32,250
-150,000 vol $0.215 each |
||
Filed 2018-11-05 Tx date 2018-10-31 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Digital Coins or Tokens
36 - Conversion or exchange
|
$6,000
+1,500 vol $4.00 each |
||
Filed 2018-11-05 Tx date 2018-10-31 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-31,500
-150,000 vol $0.21 each |
||
Filed 2018-11-05 Tx date 2018-10-31 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Digital Coins or Tokens
36 - Conversion or exchange
|
$6,000
+1,500 vol $4.00 each |
||
Filed 2018-11-05 Tx date 2018-10-31 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-31,500
-150,000 vol $0.21 each |
||
Filed 2018-11-05 Tx date 2018-10-31 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-31,500
-150,000 vol $0.21 each |
0 | |
Filed 2018-11-05 Tx date 2018-01-22 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-11-05 Tx date 2018-01-22 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
Filed 2018-11-05 Tx date 2018-01-22 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Digital Coins or Tokens
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-11-05 Tx date 2018-01-22 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-11-05 Tx date 2018-10-31 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Digital Coins or Tokens
36 - Conversion or exchange
|
$6,000
+1,500 vol $4.00 each |
||
Filed 2018-11-05 Tx date 2018-10-31 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-32,250
-150,000 vol $0.215 each |
||
Filed 2018-11-05 Tx date 2018-10-31 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Digital Coins or Tokens
36 - Conversion or exchange
|
$6,000
+1,500 vol $4.00 each |
1,500 | |
Filed 2018-11-05 Tx date 2018-10-31 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Digital Coins or Tokens
36 - Conversion or exchange
|
$6,000
+1,500 vol $4.00 each |
3,000 | |
Filed 2018-02-06 Tx date 2017-09-18 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+100,000 vol $0.25 each |
100,000 | |
Filed 2018-02-06 Tx date 2017-09-18 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-31 Tx date 2018-01-22 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-31 Tx date 2018-01-22 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-31 Tx date 2018-01-22 |
$CSQ
Canamex Gold Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-05-25 Tx date 2017-05-19 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,500
-100,000 vol $0.205 each |
169,191 | |
Filed 2017-05-12 Tx date 2017-05-08 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,960
-68,000 vol $0.22 each |
269,191 | |
Filed 2017-05-12 Tx date 2017-05-08 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,560
-72,000 vol $0.23 each |
337,191 | |
Filed 2017-05-05 Tx date 2017-05-02 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-18,000
-300,000 vol $0.06 each |
150,000 | |
Filed 2017-05-05 Tx date 2017-05-02 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,000
+300,000 vol $0.06 each |
409,191 | |
Filed 2017-05-04 Tx date 2017-05-02 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,750
-50,000 vol $0.255 each |
309,191 | |
Filed 2017-05-04 Tx date 2017-05-02 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,500
-50,000 vol $0.25 each |
359,191 | |
Filed 2017-05-04 Tx date 2017-05-02 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,500
-100,000 vol $0.235 each |
109,191 | |
Filed 2017-05-04 Tx date 2017-05-02 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,140
-100,000 vol $0.2314 each |
209,191 | |
Filed 2017-04-26 Tx date 2017-04-04 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,370
-50,000 vol $0.2074 each |
809,191 | |
Filed 2017-04-26 Tx date 2017-04-04 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86.00
-430 vol $0.20 each |
859,191 | |
Filed 2017-04-26 Tx date 2017-04-03 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,500
-50,000 vol $0.17 each |
859,621 | |
Filed 2017-04-26 Tx date 2017-04-03 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,862.50
-73,500 vol $0.175 each |
909,621 | |
Filed 2017-04-26 Tx date 2017-04-03 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,770
-26,500 vol $0.18 each |
1,033,121 | |
Filed 2017-04-26 Tx date 2017-04-03 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,250
-50,000 vol $0.185 each |
983,121 | |
Filed 2017-04-26 Tx date 2017-04-20 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,230
-100,000 vol $0.2723 each |
409,191 | |
Filed 2017-04-26 Tx date 2017-04-06 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,125
-25,000 vol $0.205 each |
509,191 | |
Filed 2017-04-26 Tx date 2017-04-05 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,750
-150,000 vol $0.205 each |
534,191 | |
Filed 2017-04-26 Tx date 2017-04-05 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,375
-75,000 vol $0.205 each |
684,191 | |
Filed 2017-04-26 Tx date 2017-04-04 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,250
-50,000 vol $0.205 each |
759,191 | |
Filed 2017-04-03 Tx date 2017-03-24 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$90,000
+750,000 vol $0.12 each |
1,059,621 | |
Filed 2016-12-16 Tx date 2016-12-12 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$5,813
+59,621 vol $0.0975 each |
309,621 | |
Filed 2016-05-06 Tx date 2016-05-03 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+200,000 vol $0.05 each |
250,000 | |
Filed 2016-05-06 Tx date 2014-09-16 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2016-04-13 Tx date 2014-09-17 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,000
+100,000 vol $0.33 each |
100,000 | |
Filed 2016-04-13 Tx date 2015-11-02 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$4,500
+50,000 vol $0.09 each |
450,000 | |
Filed 2016-04-13 Tx date 2015-08-20 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+300,000 vol $0.06 each |
400,000 | |
Filed 2016-04-13 Tx date 2014-09-16 |
$ATT
Abattis Bioceuticals Corp. |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|